China Prescription Drugs Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • A prescription drug (also prescription medication or prescription medicine) is a pharmaceutical drug that legally requires a medical prescription to be dispensed. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Different jurisdictions have different definitions of what constitutes a prescription drug.

    This report elaborates on the current development of the Prescription Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Johnson & Johnson

    • Boehringer Ingelheim GmbH

    • Sanofi

    • Novartis International AG

    • Novo Nordisk A/S

    • Takeda Pharmaceutical

    • Merck & Co, Inc

    • Celgene Corporation

    • Eli Lilly and Company

    • Allergan PLC

    • AstraZeneca PLC

    • GlaxoSmithKline PLC

    • AbbVie, Inc

    • Teva Pharmaceutical

    • Amgen, Inc

    • Gilead Sciences, Inc

    • Pfizer, Inc

    By Type:

    • Brand Drugs

    • Generic Drug

    By Application:

    • Clinic

    • Other

    • Online Sales

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Prescription Drugs Market Overview 2018-2029

    • 1.1 China Prescription Drugs Industry Development Overview

    • 1.2 China Prescription Drugs Industry Development History

    • 1.3 China Prescription Drugs Industry Market Size (2018-2029)

    • 1.4 China Prescription Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Prescription Drugs Production Volume, Production Value and Growth Rate of Brand Drugs (2018-2029)

      • 1.4.2 China Prescription Drugs Production Volume, Production Value and Growth Rate of Generic Drug (2018-2029)

    • 1.5 China Prescription Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Prescription Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.2 China Prescription Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.3 China Prescription Drugs Sales Volume, Sales Value and Growth Rate of Online Sales (2018-2029)

      • 1.5.4 China Prescription Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Prescription Drugs Market Analysis by Region

      • 1.6.1 North China Prescription Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Prescription Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Prescription Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Prescription Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Prescription Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Prescription Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Prescription Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Prescription Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Prescription Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Prescription Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Prescription Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Prescription Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Prescription Drugs Industry Development

    Chapter 3 Prescription DrugsIndustry Chain Analysis

    • 3.1 Prescription Drugs Industry Chain

    • 3.2 Prescription Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Prescription Drugs Market

    • 3.3 Prescription Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Prescription Drugs Market

    Chapter 4 China Prescription Drugs Market, by Type

    • 4.1 China Prescription Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Prescription Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Prescription Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Prescription Drugs Production Volume and Growth Rate of Brand Drugs

      • 4.5.2 China Prescription Drugs Production Volume and Growth Rate of Generic Drug

    Chapter 5 China Prescription Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Prescription Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Prescription Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Prescription Drugs Market Size and Growth Rate of Clinic

      • 5.5.2 China Prescription Drugs Market Size and Growth Rate of Other

      • 5.5.3 China Prescription Drugs Market Size and Growth Rate of Online Sales

      • 5.5.4 China Prescription Drugs Market Size and Growth Rate of Hospital

    Chapter 6 China Prescription Drugs Market, by Region

    • 6.1 China Prescription Drugs Production Volume and Production Value, by Region

    • 6.2 China Prescription Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Prescription Drugs Market Analysis

    • 7.1 North China Prescription Drugs Market, by Type

    • 7.2 North China Prescription Drugs Market, by Application

    Chapter 8 Central China Prescription Drugs Market Analysis

    • 8.1 Central China Prescription Drugs Market, by Type

    • 8.2 Central China Prescription Drugs Market, by Application

    Chapter 9 South China Prescription Drugs Market Analysis

    • 9.1 South China Prescription Drugs Market, by Type

    • 9.2 South China Prescription Drugs Market, by Application

    Chapter 10 East China Prescription Drugs Market Analysis

    • 10.1 East China Prescription Drugs Market, by Type

    • 10.2 East China Prescription Drugs Market, by Application

    Chapter 11 Northeast China Prescription Drugs Market Analysis

    • 11.1 Northeast China Prescription Drugs Market, by Type

    • 11.2 Northeast China Prescription Drugs Market, by Application

    Chapter 12 Southwest China Prescription Drugs Market Analysis

    • 12.1 Southwest China Prescription Drugs Market, by Type

    • 12.2 Southwest China Prescription Drugs Market, by Application

    Chapter 13 Northwest China Prescription Drugs Market Analysis

    • 13.1 Northwest China Prescription Drugs Market, by Type

    • 13.2 Northwest China Prescription Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Johnson & Johnson

        • 14.1.1 Johnson & Johnson Company Profile

        • 14.1.2 Johnson & Johnson Prescription Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Boehringer Ingelheim GmbH

        • 14.2.1 Boehringer Ingelheim GmbH Company Profile

        • 14.2.2 Boehringer Ingelheim GmbH Prescription Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Sanofi

        • 14.3.1 Sanofi Company Profile

        • 14.3.2 Sanofi Prescription Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Novartis International AG

        • 14.4.1 Novartis International AG Company Profile

        • 14.4.2 Novartis International AG Prescription Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Novo Nordisk A/S

        • 14.5.1 Novo Nordisk A/S Company Profile

        • 14.5.2 Novo Nordisk A/S Prescription Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Takeda Pharmaceutical

        • 14.6.1 Takeda Pharmaceutical Company Profile

        • 14.6.2 Takeda Pharmaceutical Prescription Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Merck & Co, Inc

        • 14.7.1 Merck & Co, Inc Company Profile

        • 14.7.2 Merck & Co, Inc Prescription Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Celgene Corporation

        • 14.8.1 Celgene Corporation Company Profile

        • 14.8.2 Celgene Corporation Prescription Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Eli Lilly and Company

        • 14.9.1 Eli Lilly and Company Company Profile

        • 14.9.2 Eli Lilly and Company Prescription Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Allergan PLC

        • 14.10.1 Allergan PLC Company Profile

        • 14.10.2 Allergan PLC Prescription Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 AstraZeneca PLC

        • 14.11.1 AstraZeneca PLC Company Profile

        • 14.11.2 AstraZeneca PLC Prescription Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 GlaxoSmithKline PLC

        • 14.12.1 GlaxoSmithKline PLC Company Profile

        • 14.12.2 GlaxoSmithKline PLC Prescription Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 AbbVie, Inc

        • 14.13.1 AbbVie, Inc Company Profile

        • 14.13.2 AbbVie, Inc Prescription Drugs Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Teva Pharmaceutical

        • 14.14.1 Teva Pharmaceutical Company Profile

        • 14.14.2 Teva Pharmaceutical Prescription Drugs Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Amgen, Inc

        • 14.15.1 Amgen, Inc Company Profile

        • 14.15.2 Amgen, Inc Prescription Drugs Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Gilead Sciences, Inc

        • 14.16.1 Gilead Sciences, Inc Company Profile

        • 14.16.2 Gilead Sciences, Inc Prescription Drugs Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Pfizer, Inc

        • 14.17.1 Pfizer, Inc Company Profile

        • 14.17.2 Pfizer, Inc Prescription Drugs Market Performance

        • 14.17.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Prescription Drugs Industry Research Conclusions

    • 15.2 Prescription Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Prescription Drugs Industry Market Size (2018-2029)

    • Figure China Prescription Drugs Production Volume, Production Value and Growth Rate of Brand Drugs (2018-2029)

    • Figure China Prescription Drugs Production Volume, Production Value and Growth Rate of Generic Drug (2018-2029)

    • Figure China Prescription Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Prescription Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Prescription Drugs Sales Volume, Sales Value and Growth Rate of Online Sales (2018-2029)

    • Figure China Prescription Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Prescription Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Prescription Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Prescription Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Prescription Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Prescription Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Prescription Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Prescription Drugs Market Size and Growth Rate from 2018-2029

    • Figure Prescription Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Prescription Drugs Market Share by Type in 2018

    • Figure China Prescription Drugs Market Share by Type in 2023

    • Figure China Prescription Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Prescription Drugs Production Volume and Growth Rate of Brand Drugs (2018-2023)

    • Figure China Prescription Drugs Production Volume and Growth Rate of Generic Drug (2018-2023)

    • Figure China Prescription Drugs Market Share by Application in 2018

    • Figure China Prescription Drugs Market Share by Application in 2023

    • Figure China Prescription Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Prescription Drugs Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Prescription Drugs Market Size and Growth Rate of Other (2018-2023)

    • Figure China Prescription Drugs Market Size and Growth Rate of Online Sales (2018-2023)

    • Figure China Prescription Drugs Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Prescription Drugs Production Volume by Region (2018-2023)

    • Table China Prescription Drugs Production Volume Share by Region (2018-2023)

    • Figure China Prescription Drugs Production Volume Share by Region (2018-2023)

    • Table China Prescription Drugs Production Value by Region (2018-2023)

    • Table China Prescription Drugs Production Value Share by Region (2018-2023)

    • Figure China Prescription Drugs Production Value Share by Region (2018-2023)

    • Table China Prescription Drugs Sales Volume by Region (2018-2023)

    • Table China Prescription Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Prescription Drugs Sales Volume Share by Region (2018-2023)

    • Table China Prescription Drugs Sales Value by Region (2018-2023)

    • Table China Prescription Drugs Sales Value Share by Region (2018-2023)

    • Figure China Prescription Drugs Sales Value Share by Region (2018-2023)

    • Table North China Prescription Drugs Production Volume by Type (2018-2023)

    • Table North China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Table North China Prescription Drugs Sales Volume by Application (2018-2023)

    • Table North China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Prescription Drugs Production Volume by Type (2018-2023)

    • Table Central China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Prescription Drugs Sales Volume by Application (2018-2023)

    • Table Central China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Prescription Drugs Production Volume by Type (2018-2023)

    • Table South China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Table South China Prescription Drugs Sales Volume by Application (2018-2023)

    • Table South China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Prescription Drugs Production Volume by Type (2018-2023)

    • Table East China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Table East China Prescription Drugs Sales Volume by Application (2018-2023)

    • Table East China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Prescription Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Prescription Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Prescription Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Prescription Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Prescription Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Prescription Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Prescription Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Prescription Drugs Sales Volume Share by Application (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim GmbH Company Profile

    • Table Boehringer Ingelheim GmbH Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis International AG Company Profile

    • Table Novartis International AG Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk A/S Company Profile

    • Table Novo Nordisk A/S Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Profile

    • Table Takeda Pharmaceutical Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Celgene Corporation Company Profile

    • Table Celgene Corporation Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Allergan PLC Company Profile

    • Table Allergan PLC Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca PLC Company Profile

    • Table AstraZeneca PLC Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline PLC Company Profile

    • Table GlaxoSmithKline PLC Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table AbbVie, Inc Company Profile

    • Table AbbVie, Inc Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Company Profile

    • Table Teva Pharmaceutical Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Amgen, Inc Company Profile

    • Table Amgen, Inc Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences, Inc Company Profile

    • Table Gilead Sciences, Inc Prescription Drugs Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc Prescription Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.